Tags
- A
- Abuse
- Accelerate
- Accelerated
- Accelerated approval
- Advisory
- Advisory Committee
- Agenda
- Alzheimer
- Alzheimer's disease
- An
- Approval
- Approved
- Asse
- Assessment
- Authority
- Automatic
- Based on
- Benefit
- Benefits
- Bio
- Biogen
- Cancer
- Cancer therapies
- Center for Drug Evaluation and Research
- Challenge
- Clinical
- Clinical evidence
- Clinical trial
- Conduct
- Confirmatory trial
- Congress
- Congressional leader
- Controversy
- Critical
- Dangle
- Data
- Debate
- Deference
- Delay
- Delays
- Demonstrate
- Demonstration
- Disease
- Dozen
- Dozens
- Drug
- Drug evaluation
- Drugs
- Ease
- Efficacy
- England
- Evaluation
- Evidence
- Expert panel
- Failure
- FDA
- Fee
- Generating
- Grant
- Grapple
- Halt
- Haunt
- If
- Indication
- Journal
- Journal of Medicine
- Leader
- Legislation
- Legislative reform
- Legislature
- Lymphoma
- Manufacturing
- Meanwhile
- Medicine
- New
- New England
- Notability
- ODAC
- Oncology
- Panel
- Pharmaceutical drug
- Preliminary
- Proposals
- Question
- Range
- Reform
- Reliance
- ReNew
- Require
- Research
- Result
- Risk
- Senate
- Some
- Sponsor
- Subsequent
- Survival
- Survival rate
- The Expert
- The New England Journal of Medicine
- Therapy
- Trauma trigger
- Treat
- Trial
- Trials
- Underway
- User fee
- Verify
- Widespread
- Withdrawal